Crescita Therapeutics Inc.

Crescita Therapeutics Inc.

CTX.TO
Crescita Therapeutics Inc.CA flagToronto Stock Exchange
0.79
CAD
- -
- -
14.71MMarket Cap

Crescita Therapeutics Inc. (CTX.TO) Stock Split History

Learn about Crescita Therapeutics Inc.'s most recent 209-for-200 basis stock split on February 06, 2018. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about Crescita Therapeutics Inc.'s most recent stock split

Split Date: 2018-02-06
Split Ratio: 209:200
Price Before Split: $0.68
Price After Split: $0.65

Developer API

Get CTX.TO split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/CTX.TO

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 1.04 times more shares (a 209:200 ratio)
  • The price per share is reduced proportionally

Historical Stock Splits

A comprehensive history of Crescita Therapeutics Inc.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2018-02-06209:200No$0.68$0.65

About Crescita Therapeutics Inc.

Company overview and industry information

Crescita Therapeutics Inc. (CTX.TO) operates in the Drug Manufacturers - Specialty & Generic industry. The recent 209-for-200 stock split reflects the company's growth and strategy to make shares more accessible to a broader range of investors.

Drug Manufacturers - Specialty & Generic
Go to Crescita Therapeutics Inc. Summary

Last updated: 7/7/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.